Switzerland · Delayed Price · Currency is CHF Basilea Pharmaceutica AG Statistics
Total Valuation
SWX:BSLN has a market cap or net worth of CHF 622.27 million. The enterprise value is 551.69 million.
| Market Cap | 622.27M |
| Enterprise Value | 551.69M |
Important Dates
The next confirmed earnings date is Tuesday, August 18, 2026.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SWX:BSLN has 12.40 million shares outstanding. The number of shares has decreased by -1.23% in one year.
| Current Share Class | 12.40M |
| Shares Outstanding | 12.40M |
| Shares Change (YoY) | -1.23% |
| Shares Change (QoQ) | -2.36% |
| Owned by Insiders (%) | 0.68% |
| Owned by Institutions (%) | 34.72% |
| Float | 12.31M |
Valuation Ratios
The trailing PE ratio is 15.98 and the forward PE ratio is 11.79.
| PE Ratio | 15.98 |
| Forward PE | 11.79 |
| PS Ratio | 2.68 |
| PB Ratio | 4.86 |
| P/TBV Ratio | 4.88 |
| P/FCF Ratio | 10.46 |
| P/OCF Ratio | 10.02 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.81, with an EV/FCF ratio of 9.28.
| EV / Earnings | 13.71 |
| EV / Sales | 2.37 |
| EV / EBITDA | 9.81 |
| EV / EBIT | 10.56 |
| EV / FCF | 9.28 |
Financial Position
The company has a current ratio of 5.11, with a Debt / Equity ratio of 0.70.
| Current Ratio | 5.11 |
| Quick Ratio | 4.53 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 1.59 |
| Debt / FCF | 1.50 |
| Interest Coverage | 15.56 |
Financial Efficiency
Return on equity (ROE) is 38.52% and return on invested capital (ROIC) is 79.90%.
| Return on Equity (ROE) | 38.52% |
| Return on Assets (ROA) | 12.10% |
| Return on Invested Capital (ROIC) | 79.90% |
| Return on Capital Employed (ROCE) | 22.45% |
| Weighted Average Cost of Capital (WACC) | 6.12% |
| Revenue Per Employee | 1.23M |
| Profits Per Employee | 212,910 |
| Employee Count | 189 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 5.46 |
Taxes
In the past 12 months, SWX:BSLN has paid 5.64 million in taxes.
| Income Tax | 5.64M |
| Effective Tax Rate | 12.28% |
Stock Price Statistics
The stock price has increased by +11.19% in the last 52 weeks. The beta is 0.41, so SWX:BSLN's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +11.19% |
| 50-Day Moving Average | 53.71 |
| 200-Day Moving Average | 51.43 |
| Relative Strength Index (RSI) | 29.61 |
| Average Volume (20 Days) | 26,356 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:BSLN had revenue of CHF 232.38 million and earned 40.24 million in profits. Earnings per share was 3.14.
| Revenue | 232.38M |
| Gross Profit | 87.16M |
| Operating Income | 52.25M |
| Pretax Income | 45.88M |
| Net Income | 40.24M |
| EBITDA | 54.06M |
| EBIT | 52.25M |
| Earnings Per Share (EPS) | 3.14 |
Balance Sheet
The company has 159.80 million in cash and 89.22 million in debt, with a net cash position of 70.58 million or 5.69 per share.
| Cash & Cash Equivalents | 159.80M |
| Total Debt | 89.22M |
| Net Cash | 70.58M |
| Net Cash Per Share | 5.69 |
| Equity (Book Value) | 127.94M |
| Book Value Per Share | 10.41 |
| Working Capital | 202.52M |
Cash Flow
In the last 12 months, operating cash flow was 62.09 million and capital expenditures -2.62 million, giving a free cash flow of 59.47 million.
| Operating Cash Flow | 62.09M |
| Capital Expenditures | -2.62M |
| Depreciation & Amortization | 1.81M |
| Net Borrowing | n/a |
| Free Cash Flow | 59.47M |
| FCF Per Share | 4.80 |
Margins
Gross margin is 37.51%, with operating and profit margins of 22.48% and 17.32%.
| Gross Margin | 37.51% |
| Operating Margin | 22.48% |
| Pretax Margin | 19.74% |
| Profit Margin | 17.32% |
| EBITDA Margin | 23.26% |
| EBIT Margin | 22.48% |
| FCF Margin | 25.59% |
Dividends & Yields
SWX:BSLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.23% |
| Shareholder Yield | 1.23% |
| Earnings Yield | 6.47% |
| FCF Yield | 9.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SWX:BSLN is 89.90, which is 81.25% higher than the current price. The consensus rating is "Buy".
| Price Target | 89.90 |
| Price Target Difference | 81.25% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SWX:BSLN has an Altman Z-Score of 0.15 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.15 |
| Piotroski F-Score | 5 |